---
category: news
title: "Kiromic BioPharma Announces Changes in Management, Board of Directors"
excerpt: "artificial intelligence (AI) platform to discover and develop cell and gene therapies with a therapeutic focus on immuno-oncology and other diseases. Kiromic is in the process of developing a multi-indication allogeneic CAR-T cell therapy that exploits the ..."
publishedDateTime: 2022-02-03T14:32:00Z
originalUrl: "https://stockhouse.com/news/press-releases/2022/02/03/kiromic-biopharma-announces-changes-in-management-board-of-directors"
webUrl: "https://stockhouse.com/news/press-releases/2022/02/03/kiromic-biopharma-announces-changes-in-management-board-of-directors"
type: article
quality: 4
heat: 4
published: false

provider:
  name: Stockhouse
  domain: stockhouse.com

topics:
  - AI in Healthcare
  - AI

secured: "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;XcQjvB6ZkOWXdNv9hADJEg=="
---

